Akeega, an oral dual mechanism therapy pairing niraparib with abiraterone, has won a positive committee opinion in Europe for men with early metastatic prostate cancer and DNA repair mutations.
Medscape News Europe
Source link : https://www.medscape.com/viewarticle/dual-action-tablet-gets-eu-nod-early-prostate-cancer-2026a100038l?src=rss
Author :
Publish date : 2026-02-02 13:23:00
Copyright for syndicated content belongs to the linked Source.
